Abstract
The clinical treatment for bladder cancer is still based on the immunological stimulation of the BCG. However, in some cases this treatment is not successful enough, or in some cases, can cause some collateral effects. Then, the arising of the nanoparticles functionality and nanotechnology, opens a world of possibilities for the development of new antitumoral therapies. The TiO2 is in the…